Abstract

You have accessJournal of UrologyBladder Cancer: Epidemiology & Evaluation II1 Apr 2017MP10-17 HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION. OPEN VERSUS ROBOTIC ASSISTED TECHNIQUES. Mohamed H Zahran, Mohammed Abozaid, Diaa-eddin Taha, Benjamin Lamb, Ashwin Sridhar, Wei Shen Tan, Khaled Almekaty, Ahmed S El Hefnawy, Bedeir Ali-El-Dein., and John Kelly Mohamed H ZahranMohamed H Zahran More articles by this author , Mohammed AbozaidMohammed Abozaid More articles by this author , Diaa-eddin TahaDiaa-eddin Taha More articles by this author , Benjamin LambBenjamin Lamb More articles by this author , Ashwin SridharAshwin Sridhar More articles by this author , Wei Shen TanWei Shen Tan More articles by this author , Khaled AlmekatyKhaled Almekaty More articles by this author , Ahmed S El HefnawyAhmed S El Hefnawy More articles by this author , Bedeir Ali-El-Dein.Bedeir Ali-El-Dein. More articles by this author , and John KellyJohn Kelly More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.345AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Robotic assisted radical cystectomy and intra-corporeal diversion (iRARC) has evolved with aim to improve surgical outcomes and health related quality of life (HRQOL) of patients undergoing cystectomy. Gains in perioperative outcomes including surgical complication rate and length of stay are not apparent for iRARC when measured in the randomized controlled setting although transfusion rates are reduced. The impact of iRARC on HRQOL is not fully evaluated. We compared the HRQOL outcome of open radical cystectomy (ORC) vs iRARC in patients from two high volume centers. METHODS The study included 101 patients for whom RC and urinary diversion (52 ORC and 49 iRARC) was carried out between Jun 2011 and January 2015. All patients were disease free and completed at least 12 months of follow up. HRQOL was assessed using the European Organization for Research and Treatment of Cancer-QOL (EORTC-QLQ-C30) (English and validated Arabic version). Comparison of the HRQOL scales between both groups was performed using Mann-Whitney U test. RESULTS The mean age for patients undergoing iRARC and ORC was 66.3 and 54.1 years, respectively. The median (range) postoperative follow up for iRARC and ORC groups was 27(17-60) and 43 (13-65) months, respectively. The iRARC group included 37 males and 12 females for whom intracorporeal orthotopic neobladder (ONB) (n=15) and ileal conduit (IC) (n=35) were performed. ORC included 31 males and 21 females for whom ONB and IC were performed in 41 and 11 patients, respectively. There was a significant difference in global health status (QL2) for iRARC in comparison to ORC (median (range)) [75(0-100) vs 33.3(0-100), p= 0.003] and a difference across functional scales for iRARC in comparison to ORC group (p<0.05). Also, iRARC showed statistically significant lower symptom scales in comparison to ORC groups (p<0.05). (Figure 1) CONCLUSIONS iRARC seems to provide patients with a better HRQOL compared to ORC. Large prospective studies including matched groups are still needed to assess HRQOL in these patients. However, our results suggest that HRQOL is an important outcome measure when assessing the potential benefits of iRARC and ORC. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e114-e115 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Mohamed H Zahran More articles by this author Mohammed Abozaid More articles by this author Diaa-eddin Taha More articles by this author Benjamin Lamb More articles by this author Ashwin Sridhar More articles by this author Wei Shen Tan More articles by this author Khaled Almekaty More articles by this author Ahmed S El Hefnawy More articles by this author Bedeir Ali-El-Dein. More articles by this author John Kelly More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.